Scrip
Novo Nordisk initiates Phase I diabetes trials of an oral GLP-1 drug
15 January 2010
Asher Mullard
Please Login to read the full article.
15 January 2010
Asher Mullard
Novo Nordisk has started a Phase I trial of its diabetes drug NN9924, which the company hopes could become the first oral GLP-1 analogue.
As yet, there are only two approved GLP-1 analogues, which bind the GLP receptor and thereby increase insulin production, both of which are available in...
Please Login to read the full article.
RELATED CONTENT
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
